RxDoctor Payments Data

Timothy Hilton, APRN

Gerontology · Salem, ORNPI 1376062794

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,363 and has fallen 98.5% since, to $20 in 2025.

$2,368in general payments, 2019–2025

Across 161 payments — averaging $14.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$387
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$301
  • Collegium Pharmaceutical, Inc.$271
  • Biohaven Pharmaceutical Holding Company Ltd.$250
  • Pfizer$218
  • Amgen$158
  • plus $783 from 16 others

What the payments were for

  • Food & beverage$2,368100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,368 in reported general payments places this provider in the 85th percentile of 53 gerontology providers in Oregon.

See all gerontology providers in Oregon

Medicare billing

Part B allowed, 2024
$111,121
Medicare patients
299
Services billed
1,337

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate23$46,890
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen644$16,256
OxycontinOxycodone Hcl34$13,545
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen469$13,297
Oxycodone Hcl455$9,321
MovantikNaloxegol Oxalate14$7,030
Xtampza ErOxycodone Myristate23$5,820
Gabapentin223$3,592
Morphine Sulfate ErMorphine Sulfate71$1,818
Sumatriptan Succinate14$1,804
Fentanyl21$1,698
Diclofenac Sodium14$1,404
Tramadol Hcl108$1,093
Celecoxib52$982
Pregabalin60$945

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$218$46,89023 claims
Redhill Biopharma Inc.Movantik$30$7,03014 claims
Collegium Pharmaceutical, Inc.Xtampza Er$271$5,82023 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 53 gerontology providers in Oregon.

Other gerontology in Salem

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →